CytomX Therapeutics CTMX
$ 0.89
2.71%
Quarterly report 2024-Q3
added 11-07-2024
CytomX Therapeutics EV/EBITDA Ratio 2011-2024 | CTMX
Annual EV/EBITDA Ratio CytomX Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-3.71 | -2.8 | -1.44 | -5.92 | -18.9 | -5.29 | -2.35 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-1.44 | -18.9 | -5.77 |